DiamiR Biosciences Corp. (DIMR)

DiamiR Biosciences will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

DiamiR Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is June - May.

Millions USD. Fiscal year is Jun - May.

Year	2023	2022
Net Income	-1.32	-0.32
Depreciation & Amortization	0.09	0.12
Share-Based Compensation	0.97	0.13
Other Operating Activities	0.06	0.19
Operating Cash Flow	-0.21	0.12
Capital Expenditures	-	-0
Investing Cash Flow	-	-0
Share Issuance / Repurchase	0.1	-
Financing Cash Flow	0.1	-
Net Cash Flow	-0.11	0.12
Free Cash Flow	-0.21	0.12
Free Cash Flow Margin	-18.38%	8.36%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).